| Title |
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, March 2017
|
| DOI | 10.1007/s00432-017-2402-x |
| Pubmed ID | |
| Authors |
Francis J. Giles, Delphine Rea, Gianantonio Rosti, Nicholas C. P. Cross, Juan Luis Steegmann, Laimonas Griskevicius, Philipp le Coutre, Daniel Coriu, Ljubomir Petrov, Gert J. Ossenkoppele, Francois-Xavier Mahon, Susanne Saussele, Andrzej Hellmann, Perttu Koskenvesa, Tim H. Brümmendorf, Gunther Gastl, Fausto Castagnetti, Beatrice Vincenzi, Jens Haenig, Andreas Hochhaus |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 40 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 6 | 15% |
| Student > Master | 5 | 13% |
| Student > Ph. D. Student | 4 | 10% |
| Other | 3 | 8% |
| Researcher | 3 | 8% |
| Other | 5 | 13% |
| Unknown | 14 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 13% |
| Agricultural and Biological Sciences | 3 | 8% |
| Nursing and Health Professions | 2 | 5% |
| Arts and Humanities | 1 | 3% |
| Other | 7 | 18% |
| Unknown | 15 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2017.
All research outputs
#19,221,261
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#1,814
of 2,632 outputs
Outputs of similar age
#237,477
of 310,922 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#21
of 41 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,922 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.